The incidence of a rare and deadly tumor called primary central nervous system lymphoma (PCNSL) is two times higher in black Americans, ages 20 to 49, than in white Americans, according to a Mayo Clinic study published in the June issue of Journal of Neuro-Oncology. In patients older than 49, the results were reversed. White Americans were twice as likely as black Americans to be diagnosed with PCNSL.

Common genetic variations spread across five genes raise a person's risk of developing the most frequent type of brain tumor, gliomas, an international research team reports online in Nature Genetics.

CNN is reporting that Bob Novak has a brain tumor.

A vaccine aimed at inducing immunity to the most common and deadly type of brain tumor may stave off recurrence and more than double survival in patients, according to a new study led by researchers in Duke’s Preston Robert Tisch Brain Tumor Center.

Duke University Medical Center is the place where this morning Senator Ted Kennedy will undergo brain tumor surgery, performed by Dr. Allan Friedman.

A press release delivered around 5 this morning said Ted Kennedy will undergo brain surgery at Duke University at 9 this morning.

The News Junkie has released the in-hospital photo of Ted Kennedy, who appears to be in good spirit and holding strong. The news update is that according to CNN "Sen. Kennedy has recovered remarkably quickly from his Monday procedure and therefore will be released from the hospital today ahead of schedule," Dr. Lee Schwamm, vice chairman of the neurology department, and Dr. Larry Ronan, Kennedy's primary care physician, said in a statement Wednesday.

A new neuroimaging study at the Montreal Neurological Institute and Hospital at McGill University aims to ensure the highest quality of life for patients by assessing their cognitive skills before, during, and after brain tumour surgery. This is done by mapping the important functional brain areas surrounding the tumour in order to decrease the risks during surgery.

Research using a newly developed algorithm has significantly advanced understanding of the molecular events associated with the most common primary brain tumor in adults, human glioblastoma (GBM).

In a G&D paper published online ahead of its April 1 print publication date, Dr. William Kaelin (Dana Farber Cancer Institute) and colleagues identify a potential new neuronal tumor suppressor.

A discovery by St. Jude Children’s Research Hospital scientists suggests a safer way to treat medulloblastoma, a rare but often fatal childhood brain tumor. The group found that one of the brain’s signaling pathways inhibits the growth of the highly aggressive cancer cells.

People who receive high doses of the chemotherapy drug methotrexate to treat a certain type of brain tumor appear to live longer than people receiving other treatments, according to research published in the January 29, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.